Eroxon StimGel is a new, clinically proven alternative to oral therapy that healthcare professionals can recommend for the treatment of erectile dysfunction (ED).
This novel treatment for ED is available without prescription in the EU and UK. Eroxon offers an very good safety profile with no known serious adverse drug reactions. Eroxon comes in the form of a pleasant and easy to use clear gel which is applied locally. The user or their partner can apply the gel to the user’s glans penis.
Discover more about how you can help men with ED restore intimacy and spontaneity to their and their partner’s sex lives with Eroxon StimGel.
Mode of action kick-starts normal physiology
Eroxon StimGel has a unique evaporative physical action due to the cooling and gradual warming which stimulates nerve endings on the glans penis (neurotransmission), which leads to increased blood flow and stronger erections within 10 minutes.
Phase-3 clinical data in Europe and the US
Eroxon StimGel’s safety and efficacy is clinically proven in two phase-3 clinical trials in Europe and the US, and is approved in the EU and UK for the treatment of ED.
Excellent safety profile
Eroxon StimGel is safe for use by both the man and their partner. It has very good/favourable safety profile with no known serious adverse reactions and no known interactions with other drugs, which makes it a great option to try first in the treatment pathway.
Approved under the MDR EU rules
Eroxon StimGel has been approved in the EU under the new EU Regulation on Medical Devices (“the MDR”) with its stringent legal requirements for device performance, safety and quality.